Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
Clinical trial NCT03054363 · COMPLETED
Trial details
- NCT number
- NCT03054363
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2023-01-17
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.